Nortech Systems Inc
NSYS Nasdaq Electronic Components, Nec Financials FY2015–FY2025
Last close · Oct 23, 2026
$10.30
0.9%What Nortech Systems Inc does
No business description yet.
- Legal name
- NORTECH SYSTEMS INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 26, 2026
- Accession · CIK
- 0001493152-26-012913
0000722313
Revenue and margins
Nortech Systems Inc had $12.2M of revenue in fiscal 2025, down 15.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.1M in fiscal 2025, 17.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nortech Systems Inc returned — to shareholders in fiscal 2025. The diluted share count rose 0.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Nortech Systems Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.6M | $1.0M | $1.0M | $0.9M | $1.7M |
| Debt incl. finance leases | $1.5M | — | — | — | — |
| Net debt / EBITDA | 0.2x | — | — | — | — |
| Debt / equity | 0.0x | — | — | — | — |
| Interest coverage | 5.3x | 9.5x | 12.2x | −0.3x | 1.0x |
| Current ratio | 2.3x | 2.1x | 2.2x | 2.6x | 1.9x |
| Quick ratio | 1.4x | 1.2x | 1.4x | 1.6x | 1.2x |
| Total assets | $67.1M | $69.5M | $75.1M | $72.4M | $71.9M |
| Total liabilities | $41.0M | $41.5M | $39.8M | $38.4M | $37.4M |
| Shareholders' equity | $26.1M | $28.1M | $35.3M | $34.0M | $34.5M |
| Net debt (− = net cash) | $0.9M | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY15 | FY16 | FY17 | FY18 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ |
| Return on assets rose | — | ✓ | ✕ | ✓ | — | ✓ | ✕ | ✓ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✓ |
| Debt fell relative to assets | — | ✓ | ✓ | ✓ | — | ✓ | — | — | — | — |
| Current ratio rose | — | ✕ | ✓ | ✕ | — | ✓ | ✕ | ✓ | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✓ | ✓ | — | ✕ | ✕ | ✓ | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ | ✓ | — | ✓ | ✓ | ✓ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✓ | ✓ | ✕ | — | ✕ | ✓ | ✕ | ✓ | ✕ |
| F-score | — / 3 | 7 / 9 | 6 / 9 | 7 / 9 | — / 3 | 5 / 9 | 5 / 8 | 6 / 8 | 3 / 8 | 4 / 8 |
| Accruals ratio | −7.0% | −6.2% | −6.0% | −4.1% | −3.9% | 18.8% | −5.0% | 7.1% | 1.3% | −4.1% |
| Altman Z'' | 3.40 | 3.42 | 3.21 | 3.30 | 3.13 | 4.25 | 4.33 | 5.09 | 4.76 | 4.24 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY15 | FY16 | FY17 | FY18 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $115M | $117M | $112M | $113M | $116M | $115M | $134M | $13.4M | $14.4M | $12.2M |
| Gross profit | $12.1M | $13.8M | $12.1M | $13.3M | $12.6M | $15.9M | $20.5M | $23.1M | $16.7M | $18.0M |
| Research and development | — | — | — | — | — | $0.5M | $1.5M | $1.2M | $1.2M | $1.2M |
| Operating income | −$0.4M | $0.6M | −$1.3M | $1.2M | $0.2M | $2.3M | $3.9M | $6.0M | −$0.2M | $1.0M |
| Interest expense | $0.5M | $0.6M | $0.6M | $0.8M | $1.0M | $0.4M | $0.4M | $0.5M | $0.7M | $1.0M |
| Pretax income | −$0.9M | $0.1M | −$2.1M | $0.5M | −$0.8M | $8.0M | $3.5M | $5.5M | −$0.9M | $0.0M |
| Income tax | −$0.3M | $0.0M | $0.4M | $0.3M | $0.4M | $0.9M | $1.5M | −$1.4M | $0.4M | $0.3M |
| Net income | −$0.6M | $0.0M | −$2.4M | $0.2M | −$1.2M | $7.2M | $2.0M | $6.9M | −$1.3M | −$0.3M |
| Diluted EPS | −$0.21 | $0.02 | −$0.89 | $0.06 | −$0.46 | $2.54 | $0.70 | $2.38 | −$0.47 | −$0.09 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $3.4M | $3.5M | $0.8M | $2.4M | $1.0M | −$4.5M | $5.4M | $1.8M | −$2.3M | $2.7M |
| Capital expenditure | $1.7M | $2.0M | $0.8M | $1.4M | $0.7M | $1.3M | $2.4M | $1.3M | $1.3M | $0.7M |
| Free cash flow | $1.7M | $1.6M | −$0.0M | $1.0M | $0.3M | −$5.8M | $3.0M | $0.5M | −$3.5M | $2.1M |
| Depreciation and amortization | $2.2M | $2.1M | $2.2M | $1.9M | $1.9M | $1.8M | $1.8M | $1.9M | $1.6M | $1.3M |
| Stock-based compensation | $0.0M | $0.0M | $0.0M | $0.1M | $0.3M | $0.1M | $0.3M | $0.4M | $0.5M | $0.5M |
| Share buybacks | — | — | $0.0M | $0.3M | $0.1M | — | — | — | — | — |
| Dividends and buybacks | — | — | $0.0M | $0.3M | $0.1M | — | — | — | — | — |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.0M | $0.3M | $0.5M | $0.5M | $0.4M | $0.6M | $1.0M | $1.0M | $0.9M | $1.7M |
| Total debt | $7.6M | $6.5M | $5.4M | $4.4M | $7.1M | $0.0M | — | — | — | — |
| Finance lease liabilities | — | — | — | — | $1.8M | $1.5M | $1.0M | $0.6M | $0.5M | $0.9M |
| Current assets | $40.4M | $39.5M | $37.8M | $45.9M | $41.0M | $51.8M | $54.9M | $58.8M | $55.3M | $56.2M |
| Current liabilities | $19.7M | $20.3M | $18.0M | $24.9M | $19.5M | $22.3M | $26.4M | $26.6M | $21.4M | $29.8M |
| Inventory | $20.2M | $20.7M | $18.5M | $17.0M | $13.9M | $19.4M | $22.4M | $21.7M | $21.6M | $20.7M |
| Property and equipment, net | $10.5M | $10.3M | $10.2M | $10.2M | $6.4M | $5.8M | $6.4M | $6.5M | $6.2M | $5.2M |
| Goodwill | $3.3M | $3.3M | $2.4M | $2.4M | — | — | — | — | — | — |
| Intangible assets | $2.1M | $1.9M | $1.7M | $1.5M | $1.2M | $0.5M | $0.4M | $0.3M | $0.1M | $0.1M |
| Total assets | $56.6M | $55.5M | $52.1M | $60.0M | $57.6M | $67.1M | $69.5M | $75.1M | $72.4M | $71.9M |
| Total liabilities | $34.3M | $33.2M | $32.3M | $38.9M | $38.9M | $41.0M | $41.5M | $39.8M | $38.4M | $37.4M |
| Preferred stock | $0.3M | $0.3M | $0.3M | $0.3M | $0.3M | $0.3M | $0.3M | $0.3M | $0.3M | $0.3M |
| Shareholders' equity | $22.3M | $22.3M | $19.8M | $21.1M | $18.7M | $26.1M | $28.1M | $35.3M | $34.0M | $34.5M |
| Margins | ||||||||||
| Gross margin | 10.5% | 11.9% | 10.8% | 11.7% | 10.8% | 13.8% | 15.3% | 172.0% | 116.4% | 147.4% |
| Operating margin | −0.4% | 0.5% | −1.1% | 1.1% | 0.2% | 2.0% | 2.9% | 44.3% | −1.4% | 8.0% |
| EBITDA margin | 1.5% | 2.3% | 0.8% | 2.8% | 1.8% | 3.5% | 4.2% | 58.4% | 10.1% | 18.4% |
| Net margin | −0.5% | 0.0% | −2.2% | 0.1% | −1.1% | 6.2% | 1.5% | 51.2% | −9.0% | −2.1% |
| FCF margin | 1.5% | 1.4% | −0.0% | 0.9% | 0.2% | −5.1% | 2.3% | 3.6% | −24.5% | 17.0% |
| Returns | ||||||||||
| Return on capital | −1.1% | 1.4% | −4.1% | 3.2% | 0.7% | 8.0% | — | — | — | — |
| Return on capital employed | −1.1% | 1.8% | −3.7% | 3.6% | 0.6% | 5.1% | 9.0% | 12.3% | −0.4% | 2.3% |
| Return on equity | −2.6% | 0.2% | −11.6% | 0.8% | −6.6% | 31.9% | 7.4% | 21.7% | −3.7% | −0.7% |
| Return on assets | −1.0% | 0.1% | −4.5% | 0.3% | −2.1% | 11.5% | 2.9% | 9.5% | −1.8% | −0.3% |
| Return on tangible equity | −3.4% | 0.3% | −15.6% | 1.0% | −7.0% | 27.9% | 7.3% | 19.6% | −3.8% | −0.7% |
| Growth | ||||||||||
| Revenue growth | — | 1.2% | −3.7% | 0.9% | — | −1.0% | 16.5% | −90.0% | 7.0% | −15.0% |
| Net income growth | — | — | −5,684.5% | — | — | — | −71.9% | 242.0% | −118.8% | — |
| EPS growth | — | — | −4,550.0% | — | — | — | −72.4% | 240.0% | −119.7% | — |
| FCF growth | — | −7.3% | −100.4% | — | — | −2,197.8% | — | −84.0% | −825.8% | — |
| Share count change | — | 0.1% | −0.1% | −1.7% | — | 5.9% | 2.5% | −0.2% | −4.5% | 0.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.4x | 2.3x | 5.3x | 1.3x | 4.0x | 0.2x | — | — | — | — |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.2x | 0.4x | 0.0x | — | — | — | — |
| Interest coverage | −0.9x | 1.1x | −2.0x | 1.6x | 0.2x | 5.3x | 9.5x | 12.2x | −0.3x | 1.0x |
| Current ratio | 2.1x | 1.9x | 2.1x | 1.8x | 2.1x | 2.3x | 2.1x | 2.2x | 2.6x | 1.9x |
| Quick ratio | 1.0x | 0.9x | 1.1x | 1.2x | 1.4x | 1.4x | 1.2x | 1.4x | 1.6x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.5% | 1.7% | 0.7% | 1.2% | 0.6% | 1.1% | 1.8% | 9.6% | 8.8% | 5.4% |
| Stock comp / revenue | 0.0% | 0.0% | 0.0% | 0.1% | 0.2% | 0.1% | 0.2% | 3.1% | 3.2% | 4.1% |
| Payouts / FCF | — | — | — | 26.4% | 46.8% | — | — | — | — | — |
| Quality scores | ||||||||||
| Piotroski F-score | — | 7.0 | 6.0 | 7.0 | — | 5.0 | 5.0 | 6.0 | 3.0 | 4.0 |
| Altman Z'' | 3.4 | 3.4 | 3.2 | 3.3 | 3.1 | 4.3 | 4.3 | 5.1 | 4.8 | 4.2 |
| Accruals ratio | −7.0% | −6.2% | −6.0% | −4.1% | −3.9% | 18.8% | −5.0% | 7.1% | 1.3% | −4.1% |
Source: SEC EDGAR XBRL filings (CIK 0000722313). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
